Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Godfrey

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Journal of the International AIDS Society|August 9, 2020
PEPFAR's response to the convergence of the HIV and COVID-19 pandemics in Sub-Saharan AfricaRachel Golin, Catherine Godfrey, Jacqueline Firth, et al.
BMC Infectious Diseases|June 12, 2016
A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countriesCatherine Godfrey, Gail Tauscher, Sally Hunsberger, et al.
Clinical Pharmacology and Therapeutics|June 21, 2021
A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug-Drug Interactions With Antiretroviral and Antituberculosis TreatmentJose Francis, Rosie Mngqibisa, Helen McIlleron, et al.
The Journal of Infectious Diseases|October 4, 2017
Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases ConsultationCatherine Godfrey, Michael C Thigpen, Keith W Crawford, et al.
AIDS Patient Care and Stds|November 17, 2021
Participants Switching to Second-Line Antiretroviral Therapy with Susceptible Virus Display Inferior Adherence and Worse Outcomes: An Observational AnalysisLentlametse Mantshonyane, Jason Roy, Michael Z Levy, et al.
AIDS Research and Therapy|December 30, 2024
Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infectionRosie Mngqibisa, Huichao Chen, Catherine Godfrey, et al.
AIDS Research and Therapy|April 8, 2025
Correction: Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infectionRosie Mngqibisa, Huichao Chen, Catherine Godfrey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 27, 2020
Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral TherapyJordan E Lake, Kunling Wu, Sara H Bares, et al.
AIDS and Behavior|March 17, 2016
HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United StatesRaphael J Landovitz, Thuy Tien T Tran, Susan E Cohn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2014
Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227Mary A Vogler, Laura M Smeaton, Rodney L Wright, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Journal of the International AIDS Society|August 9, 2020
PEPFAR's response to the convergence of the HIV and COVID-19 pandemics in Sub-Saharan AfricaRachel Golin, Catherine Godfrey, Jacqueline Firth, et al.
BMC Infectious Diseases|June 12, 2016
A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countriesCatherine Godfrey, Gail Tauscher, Sally Hunsberger, et al.
Clinical Pharmacology and Therapeutics|June 21, 2021
A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug-Drug Interactions With Antiretroviral and Antituberculosis TreatmentJose Francis, Rosie Mngqibisa, Helen McIlleron, et al.
The Journal of Infectious Diseases|October 4, 2017
Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases ConsultationCatherine Godfrey, Michael C Thigpen, Keith W Crawford, et al.
AIDS Patient Care and Stds|November 17, 2021
Participants Switching to Second-Line Antiretroviral Therapy with Susceptible Virus Display Inferior Adherence and Worse Outcomes: An Observational AnalysisLentlametse Mantshonyane, Jason Roy, Michael Z Levy, et al.
AIDS Research and Therapy|December 30, 2024
Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infectionRosie Mngqibisa, Huichao Chen, Catherine Godfrey, et al.
AIDS Research and Therapy|April 8, 2025
Correction: Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infectionRosie Mngqibisa, Huichao Chen, Catherine Godfrey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 27, 2020
Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral TherapyJordan E Lake, Kunling Wu, Sara H Bares, et al.
AIDS and Behavior|March 17, 2016
HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United StatesRaphael J Landovitz, Thuy Tien T Tran, Susan E Cohn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2014
Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227Mary A Vogler, Laura M Smeaton, Rodney L Wright, et al.
Pageof 11